nickel has been researched along with elesclomol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kord, AS; Liu, DQ; Vogt, FG; Wu, L; Zhou, L | 1 |
| Hasinoff, BB; Patel, D; Wu, X; Yadav, AA | 1 |
2 other study(ies) available for nickel and elesclomol
| Article | Year |
|---|---|
LC-MS/MS and density functional theory study of copper(II) and nickel(II) chelating complexes of elesclomol (a novel anticancer agent).
Topics: Antineoplastic Agents; Calibration; Chelating Agents; Chromatography, Liquid; Copper; Gases; Hydrazines; Ligands; Models, Molecular; Nickel; Oxidation-Reduction; Solutions; Tandem Mass Spectrometry | 2011 |
Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Topics: Antineoplastic Agents; Ascorbic Acid; Cations, Divalent; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Hydrazines; K562 Cells; Kinetics; Models, Molecular; Nickel; Oxidation-Reduction; Platinum; Reactive Oxygen Species; Trientine | 2013 |